Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     

PFIZER, INC.

(PFE)
  Report
Real-time Estimate Cboe BZX  -  08:21 2022-09-26 am EDT
43.70 USD   -0.86%
07:31aPfizer, BioNTech Submit US FDA Emergency Use Application For Omicron-Adapted Vaccine For Children
MT
07:20aPfizer/BioNTech seek FDA nod for new COVID boosters for children
RE
07:05aPfizer, BioNTech File FDA Application for Emergency Use Authorization of Omicron-Specific Vaccine in Children
MT
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Morgan Stanley Adjusts Pfizer's Price Target to $49 From $52, Keeps Equalweight Rating

07/08/2022 | 09:14am EDT


© MT Newswires 2022
All news about PFIZER, INC.
07:31aPfizer, BioNTech Submit US FDA Emergency Use Application For Omicron-Adapted Vaccine Fo..
MT
07:20aPfizer/BioNTech seek FDA nod for new COVID boosters for children
RE
07:05aPfizer, BioNTech File FDA Application for Emergency Use Authorization of Omicron-Specif..
MT
06:54aPfizer seeks FDA nod for Omicron-retooled booster for kids aged 5-11 yrs
RE
06:46aPfizer and BioNTech Submit Application to U.S. FDA for Emergency Use Authorization of O..
BU
05:42aPfizer, BioNTech Ask FDA to Approve Booster for Children
DJ
02:07aGSK picks Burberry's Brown as first female CFO
RE
09/25NEWS HIGHLIGHTS : Top Company News of the Day
DJ
09/24Pfizer CEO tests positive for COVID
RE
09/23Healthcare Shares Slip But Perform Better Than Broader Market -- Healthcare Roundup
DJ
More news
Analyst Recommendations on PFIZER, INC.
More recommendations
Financials (USD)
Sales 2022 102 B - -
Net income 2022 32 739 M - -
Net cash 2022 10 262 M - -
P/E ratio 2022 7,78x
Yield 2022 3,68%
Capitalization 247 B 247 B -
EV / Sales 2022 2,33x
EV / Sales 2023 2,90x
Nbr of Employees 79 000
Free-Float 59,0%
Chart PFIZER, INC.
Duration : Period :
Pfizer, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends PFIZER, INC.
Short TermMid-TermLong Term
TrendsBearishBearishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 22
Last Close Price 44,08 $
Average target price 55,75 $
Spread / Average Target 26,5%
EPS Revisions
Managers and Directors
Albert Bourla Chairman, Chief Executive & Operating Officer
David M. Denton Chief Financial Officer & Executive Vice President
Mikael Dolsten Executive VP, President-Research & Development
Lidia L. Fonseca Executive VP, Chief Digital & Technology Officer
Aida Habtezion Chief Medical Officer
Sector and Competitors
1st jan.Capi. (M$)
PFIZER, INC.-25.35%247 392
JOHNSON & JOHNSON-2.54%438 337
ELI LILLY AND COMPANY12.76%295 941
ROCHE HOLDING AG-18.41%259 291
ABBVIE INC.5.66%252 944
NOVO NORDISK A/S1.95%221 838